Soterias Medical

Soterias Medical started intial phases of research and development in May 2014. Since then, the company has been able to collaborate with dermatologists from MedStar Union Memorial and Johns Hopkins Hospital, who have shared their methodologies with the company. Their feedback has inspired several iterations of the device's design.

​

Soterias Medical's dermal injector addresses the biological hurdles associated with stem cell delivery by including controls to precisely adjust injection rate, integrated cell thawing capabilities, and a closed-loop delivery system that reduces the risk of contamination. Stem cells are commonly stored and frozen in cryogenic vials, which typically hold a one to two milliliter volume. Soterias Medical will make use of cryobags, which can hold volumes ranging from five to ten milliliters. This reduces the number of times the physician has to reload the device -- effectively decreasing procedure time and the risk of contamination.  The cryobag will be connected to tubing and a needle to form the closed-loop system.  The physicians will thread the tubing through a peristaltic pump which will accurately output desired volumes for each injection.  The integrated cell thawing system heats frozen stem cells at a consistent rate, which dramatically improves cell viability.

The dermal injector will be kept in its base station when not in use.  This docking station will charge the device and will be used to adjust device settings.  Every system in the dermal injector will be controlled electronically. All the physician has to do is input his or her desired injection volume, injection rate, and start the thawing process using buttons on the base station. The LED screen on the base station will indicate when cell thawing is complete and will alert the physician when the device is ready to use.